Book Review: Bad Blood – Secrets and Lies in a Silicon Valley Startup
Article Sidebar
Published:
May 17, 2019
Keywords:
fraud, Theranos, Carreyrou, innovation, medicine
Main Article Content
Abstract
This book review appraises John Carreyrou’s non-fiction book Bad Blood. The text provides penetrating insights on Theranos, an American laboratory diagnostics company that promised to revolutionize laboratory medicine. The author’s award-winning prose relays the events leading to the eventual discovery of fraud at Theranos as well as the subsequent collapse of the company. The book can be faulted for being unripe. Publication prior to a full resolution to the Theranos affair precludes analysis of the longer-term impacts of this fraud. Notwithstanding Bad Blood’s imperfect timing, the book remains a seminal text amidst journalistic chronicles of medical innovation gone wrong.
Article Details
Section
Commentary
- Authors publishing in the UOJM retain copyright of their articles, including all the drafts and the final published version in the journal.
- While UOJM does not retain any rights to the articles submitted, by agreeing to publish in UOJM, authors are granting the journal right of first publication and distribution rights of their articles.
- Authors are free to submit their works to other publications, including journals, institutional repositories or books, with an acknowledgment of its initial publication in UOJM.
- Copies of UOJM are distributed both in print and online, and all materials will be publicly available online. The journal holds no legal responsibility as to how these materials will be used by the public.
- Please ensure that all authors, co-authors and investigators have read and agree to these terms.
- Works are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Carreyrou J. Bad Blood - Secrets and Lies in a Silicon Valley Startup. New York: Alfred A. Knopf, Inc.; 2018. 339 p.